METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
批准号:
2897875
负责人:
Bryan K Yamamoto
金额:
$22.92万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-15 至 2000-05-31
关键词:
aminoacid inhibitor calpain corpus striatum corticosterone dopamine experimental brain lesion gamma aminobutyrate glutamates glutathione hydroxyl radical ibotenate immunocytochemistry laboratory rat lipid metabolism methamphetamine neural transmission neuropharmacology neurotoxins peroxidation spectrin thalamic nuclei tyrosine 3 monooxygenase western blottings
中文摘要
甲基苯丙胺(METH)是一种滥用药物,对
中枢神经系统包括精神活动和情绪升高。 这些影响
导致了它的高滥用倾向。此外,长期使用
产生了类似偏执型精神分裂症的行为模式这些
行为副作用和滥用的可能性表明,
对中枢神经系统的长期神经毒性作用。 然而,确切的机制
甲基苯丙胺损伤多巴胺神经元的机制尚不清楚。兴奋性氨基酸
如谷氨酸盐与甲基苯丙胺诱导的
多巴胺
本提案的主要目的是阐明
潜在的METH毒性,并侧重于谷氨酸依赖性机制
介导METH对纹状体多巴胺毒性作用的反应
神经元 谷氨酸传输和代谢的药理学操作
多巴胺和谷氨酸的细胞外浓度的体内测量
使用微透析。此外,细胞反应
将通过测量METH和谷氨酸诱导的神经毒性来评估
血影蛋白分解、羟基自由基形成和脂质过氧化。
第一系列的实验将评估是否改变
细胞外谷氨酸浓度影响甲基苯丙胺诱导的纹状体
多巴胺缺乏第二个具体目标是破坏
损毁腹侧皮质纹状体神经递质传递
丘脑核这些病变对METH诱导的
纹状体细胞外谷氨酸浓度及其长期效应
纹状体多巴胺含量和酪氨酸羟化酶免疫反应性
将被确定。 第三和第四个具体目标将决定
细胞外浓度增加的细胞毒性后果
多巴胺和谷氨酸通过测量血影蛋白的蛋白水解程度,
羟基自由基及其伴随神经毒性的产生
脂质过氧化反应所显示的影响。最终目标是评估
反复的压力事件的影响,
反复给予低剂量的甲基或皮质酮,
METH对前脑多巴胺神经元后续毒性作用
地区 总的来说,这些实验具有显著的临床意义。
毒性兴奋性氨基酸的影响,
环境压力因素和/或既往药物暴露作为决定因素,
药物引起的神经毒性的后果。 因为压力有很强的
影响对自我管理安非他明的敏感性,这些
研究也与先前暴露于
神经毒性剂量的METH对药物寻求行为和对
压力事件
英文摘要
Methamphetamine (METH) is a drug of abuse with pronounced effects on the
CNS including psychomotor activation and mood elevation. These effects
have contributed to its high abuse liability. Furthermore, prolonged used
has produced a behavioral pattern resembling paranoid schizophrenia. These
behavioral side effects and abuse potential suggest that METH produces
long-lasting neurotoxic effects in the CNS. However, the exact mechanisms
by which METH damages dopamine neurons are unknown. Excitatory amino acids
such as glutamate have been implicated in the METH-induced depletions of
dopamine.
The primary objective of this proposal is to elucidate the factors
underlying METH toxicity and focuses on the glutamate-dependent mechanisms
and responses mediating the toxic effects of METH to striatal dopamine
neurons. Pharmacological manipulations of glutamate transmission and in
vivo measures of extracellular concentrations of dopamine and glutamate
using microdialysis will be employed. In addition, the cellular responses
to METH and glutamate-induced neurotoxicity will be assessed by measuring
spectrin breakdown, hydroxyl radical formation, and lipid peroxidation.
The first series of experiments will evaluate whether alterations in
extracellular glutamate concentrations affect METH-induced striatal
dopamine depletIons. The second specific aim will be to disrupt
corticostriatal glutamatergic transmission by lesioning the ventral
thalamic nuclei. The effects of these lesions on METH induced increases in
striatal extra cellular glutamate concentrations and its long term effects
on striatal dopamine content and tyrosine hydroxylase immunoreactivity
will be determined. The third and fourth specific aims will determine the
cytotoxic consequences of the increased extracellular concentrations of
dopamine and glutamate by measuring the degree of spectrin proteolysis,
the production of hydroxyl free radicals and their attendant neurotoxic
effects indicated by lipid peroxidation. The final aim will be to evaluate
the effects of repeated stress episodes and
repeated administrations of low doses of METH or corticosterone on the
subsequent neurotoxic effects of METH to dopamine neurons in forebrain
regions. Overall, these experiments have significant clinical
implications for the influence of toxic excitatory amino acids,
environmental stressors, and/or prior drug exposure as determinants and
consequences of drug-induced neurotoxicity. Since stress has a strong
influence on the susceptibility to self administer amphetamine, these
studies are also relevant to the consequences of prior exposure to
neurotoxic doses of METH on drug seeking behavior and the reactivity to
stressful events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methamphetamine-Alcohol Interactions and Mechanisms of Augmented Toxicity to Brain and Peripheral Organs
-
批准号:9381361
-
项目类别:
-
资助金额:$50.68万
-
财政年份:2017
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:8599015
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:8661737
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:9122805
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:9044745
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7795247
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7196550
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7579929
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7664115
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7032142
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7367125
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6872592
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6694381
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:7070101
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6921502
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6778353
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120086
-
项目类别:
-
资助金额:$13.07万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120088
-
项目类别:
-
资助金额:$20.1万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120087
-
项目类别:
-
资助金额:$21.4万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine Toxicity and Corticostriatal Glutamate
-
批准号:7816726
-
项目类别:
-
资助金额:$47.22万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
国内基金
海外基金
登录
查看更多内容
神经元上Navβ2-ICD/NMDAR/Ca2+/Calpain介导的异常神经兴奋性在AD诱导的遗忘加速中的作用研究
-
批准号:82560226
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:习杨彦彬
-
依托单位:
Wnt5a/Calpain6/Rac1通路激活毛囊黑素干细胞逆转毛发白化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:星懿展
-
依托单位:
矢车菊素-3-O-葡萄糖苷通过miR-137-3p抑制Calpain-2/β-catenin通路降低胶质瘤细胞干性的信号机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
Calpain活化在线粒体稳态失衡引起噪声性耳蜗损伤中的作用机制
-
批准号:82330034
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:殷善开
-
依托单位:
Calpain通过MYC-DHODH促进铁死亡介导早期心肌损伤在病毒性心肌炎中的作用及机制研究
-
批准号:82370361
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈瑞珍
-
依托单位:
Calpain/P-eIF2α动态平衡在黄芪甲苷IV治疗顺铂肾损伤中的机制研究
-
批准号:82360738
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:寇温
-
依托单位:
热休克蛋白90对calpain-1的变构调节机制及其对鸡肉嫩度的影响
-
批准号:32372406
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张牧焓
-
依托单位:
靶向抑制线粒体calpain截切ATP5A1蛋白在防治心力衰竭中的关键作用和机制研究
-
批准号:82370388
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:曹婷
-
依托单位:
Calpain调节Kupffer细胞内质网应激介导NLRP3活化促进肝纤维化的机制研究
-
批准号:2023JJ40913
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:杨慧
-
依托单位:
Calpain调控KCC2通路在脑损伤后海马认知功能障碍中的作用及机制
-
批准号:LY23H090012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:洪远
-
依托单位: